Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects

Kang Chen(State Key Laboratory of Synthetic Chemistry), Aimin Xu(University of Hong Kong)
Nature Communications
December 20, 2022
Cited by 36


Related Papers